Reducing adverse drug events and medication errors using rapid cycle improvement.
The article describes Fairview Health System's participation in the Institute for Healthcare Improvement Breakthrough Series on adverse drug events and medication errors. Fairview commissioned an interdisciplinary team to design, plan, and lead activities focused on reducing adverse drug events and medication errors. This team managed, facilitated, or led 15 separate projects, each focusing on a specific aspect of the medications process. Specific systems improvements were identified, leading to reductions in errors or adverse events. As a result of this effort, Fairview has committed to a long-term plan to reduce the risk of adverse drug events and medication errors to the lowest possible rate.
Meisel
S
S
Fairview Health Services, Edina, MN, USA.
Sershon
L
L
White
D
D
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D019033:Delivery of Health Care, Integrated / Q000592:standards; D064420:Drug-Related Side Effects and Adverse Reactions; D001330:Electronic Data Processing; D005568:Forms and Records Control; D005569:Formularies as Topic; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects; D008499:Medical Records; D008508:Medication Errors / Q000517:prevention & control*; D008509:Medication Systems / Q000592:standards*; D008910:Minnesota; D012076:Renal Agents / Q000008:administration & dosage / Q000009:adverse effects; D017749:Total Quality Management / Q000379:methods*; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects
D000925:Anticoagulants; D000970:Antineoplastic Agents; D006993:Hypnotics and Sedatives; D007328:Insulin; D012076:Renal Agents; D014859:Warfarin